GPC1 and pancreatic adenocarcinoma: Qian JY et al. have reported that GPC-1 in exosomes is identified as an early diagnostic biomarker for pancreatic adenocarcinoma, and the presence of GPC-1 in extracellular vesicles can serve as a predictor of RIAC outcome for patients with APC mutation [34].